BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 4731030)

  • 1. Pituitary follicle-stimulating hormone activity in rats treated with apomorphine, pimozide and drugs that modify catecholamine levels.
    Choudhury SA; Sharpe RM; Brown PS
    Neuroendocrinology; 1973; 12(4):272-83. PubMed ID: 4731030
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of changes in brain monoamine metabolism on behaviour of herpes simplex-infected mice.
    Lycke E; Roos BE
    J Neurol Sci; 1974 Jul; 22(3):277-89. PubMed ID: 4151982
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for participation of a catecholaminergic mechanism in the post-castration rise in plasma gonadotropins.
    Ojeda SR; McCann SM
    Neuroendocrinology; 1973; 12(4):295-315. PubMed ID: 4147209
    [No Abstract]   [Full Text] [Related]  

  • 4. Apomorphine induced biting and fighting behaviour in reserpinized rats and an approach to the mechanism of action.
    Patni SK; Dandiya PC
    Life Sci; 1974 Feb; 14(4):737-45. PubMed ID: 4856759
    [No Abstract]   [Full Text] [Related]  

  • 5. Pituitary follicle-stimulating hormone in immature female rats treated with drugs that inhibit the synthesis or antagonise the actions of catecholamines and 5-hydroxytryptamine.
    Brown PS
    Neuroendocrinology; 1971; 7(3):183-92. PubMed ID: 5546028
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced dopaminergic supersensitivity.
    Moore KE; Thornburg JE
    Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
    [No Abstract]   [Full Text] [Related]  

  • 7. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of brain dopamine as the probable mechanism for the hypothermic effect of D-amphetamine.
    Yehuda S; Wurtman RJ
    Nature; 1972 Dec; 240(5382):477-8. PubMed ID: 4565945
    [No Abstract]   [Full Text] [Related]  

  • 10. Involvement of norepinephrine in transmission of the stimulatory influence of progesterone on gonadotropin release.
    Kalra PS; Kalra SP; Krulich L; Fawcett CP; McCann SM
    Endocrinology; 1972 May; 90(5):1168-76. PubMed ID: 4258973
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol.
    Dunstan R; Jackson DM
    Clin Exp Pharmacol Physiol; 1977; 4(2):131-41. PubMed ID: 195762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shock-induced aggression: effects of 6-hydroxydopamine and other pharmacological agents.
    Thoa NB; Eichelman B; Ng LK
    Brain Res; 1972 Aug; 43(2):467-75. PubMed ID: 5066136
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
    Rolinski Z; Scheel-Krüger J
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):385-99. PubMed ID: 4149038
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ontogenic study on the effect of catecholamine receptor-stimulating agents on the turnover of noradrenaline and dopamine in the brain.
    Kellogg C; Wennerström G
    Brain Res; 1974 Oct; 79(3):451-64. PubMed ID: 4371328
    [No Abstract]   [Full Text] [Related]  

  • 16. Copulatory behavior in the male rat after impaired monoaminergic neurotransmission.
    Malmnäs CO
    Acta Physiol Scand Suppl; 1973; 400():69-95. PubMed ID: 4136131
    [No Abstract]   [Full Text] [Related]  

  • 17. Catecholaminergic control of gonadotropin and prolactin secretion with particular reference to the possible participation of dopamine.
    McCann SM; Ojeda SR; Fawcett CP; Krulich L
    Adv Neurol; 1974; 5():435-45. PubMed ID: 4374066
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurotransmitter control of thyrotrophin secretion in hypothyroid rats.
    Männistö PT; Ranta T
    Acta Endocrinol (Copenh); 1978 Sep; 89(1):100-7. PubMed ID: 29423
    [No Abstract]   [Full Text] [Related]  

  • 19. Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation.
    Fuxe K; Corrodi H; Hökfelt T; Lidbrink P; Ungerstedt U
    Med Biol; 1974 Apr; 52(2):121-32. PubMed ID: 4837435
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of adrenergic, dopaminergic, cholinergic and serotoninergic drugs on plasma prolactin levels in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1975 Feb; 96(2):313-8. PubMed ID: 234380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.